SYY
41
-6
NI
70
-3
GD
46
-13
GM
71
3
O
30
-3
ITW
62
-5
VRTX
53
-5
KIM
70
-3
CAH
54
-6
TDC
73
2
ETR
65
-3
COP
59
2
FSLR
47
7
AVGO
30
-5
NOC
34
-6
CVX
47
9
VRSK
82
-5
ECL
59
-3
LRCX
48
2
VTR
50
-5
SYY
41
-6
NI
70
-3
GD
46
-13
GM
71
3
O
30
-3
ITW
62
-5
VRTX
53
-5
KIM
70
-3
CAH
54
-6
TDC
73
2
ETR
65
-3
COP
59
2
FSLR
47
7
AVGO
30
-5
NOC
34
-6
CVX
47
9
VRSK
82
-5
ECL
59
-3
LRCX
48
2
VTR
50
-5
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
60

TGTX
TG Therapeutics

Last Price:
29.51
Seasonality Move:
46.51%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

TG Therapeutics Price Quote

$29.51
-1.34 (-4.33%)
(Updated: November 15, 2024 at 4:30 PM ET)

TG Therapeutics Key Stats

Buy
60
TG Therapeutics (TGTX) is a Buy
Day range:
$30.36 - $36.50
52-week range:
$10.98 - $36.50
Dividend yield:
0%
P/E ratio:
342.72
P/S ratio:
18.13
P/B ratio:
24.99%
Volume:
8.1M
Avg. volume:
3.6M
1-year change:
181.69%
Market cap:
$4.8B
Revenue:
$233.7M
EPS:
$-0.11

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.49%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.97%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 35.11% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 181.69% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $244.2M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $341M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.23

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$28.1M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $134.6M
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$61.6M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is -4.78%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -3.55%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is -8.4%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Precision BioSciences Inc (DTIL)
    • Inspire Medical Systems Inc (INSP)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Varex Imaging Corp (VREX)

TG Therapeutics Dividend Yield

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -97.26% -40.92%
Revenue: -49.41% 2.66%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 37.22
Upside from Last Price: 20.68%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    169.8M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22.1M TGTX shares are owned by insiders